The new Roche SARS-CoV-2 antibody assay has received FDA EUA for qualitative and semiquantitative detection of antibodies to SARS-CoV-2 spike (S) protein specific for the protein’s receptor binding domain. Positive results indicate the development of active immunity after vaccination. Please be advised that Boston Heart Diagnostics policy states that practitioners are unable to order labs on themselves or their immediate family members.
Covid-19 PCR SWAB
by
BostonHeart
Swab
This is a single-marker TaqPath COVID-19 (SARS-CoV-2) NP swab tes measuring COVID-19 RNA. It helps determine whether or not a patient has contracted COVID-19.
Covid-19 PCR SWAB
by
BostonHeart
Swab
This is a single-marker TaqPath COVID-19 (SARS-CoV-2) NP swab tes measuring COVID-19 RNA. It helps determine whether or not a patient has contracted COVID-19. Please be advised that Boston Heart Diagnostics policy states that practitioners are unable to order labs on themselves or their immediate family members.
COVID-19 Immune Response Panel
by
US BioTek
Serum
The COVID-19 Immune Response Panel evaluates antibodies against the nucleocapsid (N) protein and S-RBD antibodies. It provides both a positive/negative result and a semi-quantitative estimate. This test is best for patients who want to understand if they have a current or previous COVID-19 infection and/or establish a pre-vaccine baseline immune response. It can also help determine the ability of an individual's immune system to fight off a new COVID-19 exposure.
Ultra Sonic COVID-19 Antibodies™ SARS-CoV-2 IgG & IgM Total Abs
by
Access Medical Labs
Serum
This marker detects the antibodies of SARS-CoV-2, IgM which is detectable as early as 3-5 days after exposure and IgG which indicates past exposure (as recent as 14 days). The Ultra-Sonic COVID-19 test w/ Fast Track Technology is the only test in the USA of its kind.
COVID-19 IgG + IgM Antibody Panel
by
US BioTek
Serum
The COVID-19 IgG + IgM Antibody Panel evaluates IgG and IgM reactivity separately, providing individual results for each. This may be useful for determining the current stage of infection. This test is performed on a high-precision chemiluminescent immunoassay that has received FDA authorization under emergency use authorization (EUA).
SARS–CoV–2 ImmunoBlot IgG
by
IGeneX
Serum
This test detects late (IgG) stage antibodies against SARS–COV–2. Antibody positivity likely means a patient has protective immunity.
COVID-19 Vaccine Response Screen
by
US BioTek
Serum
The COVID-19 Vaccine Response Screen evaluates S-RBD antibodies and provides both a positive/negative result and a semi-quantitative estimate. This test is best for patients who have fully completed the vaccination process. It can confirm a successful antibody production response to the COVID-19 vaccination when performed after a pre-vaccination COVID-19 Immune Response Panel.
COVID-19 Ab. Qual/Quant
by
BioReference
Serum
This test assesses for immune status for SARS-CoV-2 after vaccination or infection.
Viral Panel Premier
by
Immunosciences Lab
Serum
This panel measures antibodies against six different viruses (EBV, CMV, HSV-1, HSV-2, HHV-6, VZV) that are involved in different inflammatory autoimmune diseases, chronic fatigue syndrome or myalgic encephalitis, neurodegenerative disorders such as Alzheimer’s and Parkinson’s, and neurological disorders such as Guillain-Barré syndrome and multiple sclerosis. Reactivation of these viruses is a major driver in increasing the severity of symptoms in patients with COVID-19. The test confirms immunological memory against Varicella zoster (VZV), the causative agent for shingles.